Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Neoplasms of the CNS

Free Subscription 04.03.2019 3 AJNR Am J Neuroradiol 1 Childs Nerv Syst 4 Clin Cancer Res 1 J Clin Oncol 5 J Neurooncol 2 J Neuropathol Exp Neurol 2 Neuro Oncol 2 Neurosurgery 2 Oncogene 1 PLoS Genet 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJNR Am J Neuroradiol

1. BAAL JD, Chen WC, Solomon DA, Pai JS, et al
   Preoperative MR Imaging to Differentiate Chordoid Meningiomas from Other Meningioma Histologic Subtypes.
   AJNR Am J Neuroradiol. 2019 Feb 28. pii: ajnr.A5996. doi: 10.3174/ajnr.A5996.
   PubMed     Text format     Abstract available
   
   
2. HU LS, Yoon H, Eschbacher JM, Baxter LC, et al
   Accurate Patient-Specific Machine Learning Models of Glioblastoma Invasion Using Transfer Learning.
   AJNR Am J Neuroradiol. 2019 Feb 28. pii: ajnr.A5981. doi: 10.3174/ajnr.A5981.
   PubMed     Text format     Abstract available
   
   
3. RODRIGUEZ D, Chambers T, Warmuth-Metz M, Aliaga ES, et al
   Evaluation of the Implementation of the Response Assessment in Neuro-Oncology Criteria in the HERBY Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.
   AJNR Am J Neuroradiol. 2019 Feb 28. pii: ajnr.A5982. doi: 10.3174/ajnr.A5982.
   PubMed     Text format     Abstract available
   
   

   
   Childs Nerv Syst

4. RICKLEFS FL, Fritzsche F, Winkler B, Meissner B, et al
   Relapse of a group 4 medulloblastoma after 18 years as proven by histology and DNA methylation profiling.
   Childs Nerv Syst. 2019 Feb 22. pii: 10.1007/s00381-019-04086.
   PubMed     Text format     Abstract available
   
   

   
   Clin Cancer Res

5. IPPEN FM, Alvarez-Breckenridge CA, Kuter BM, Fink AL, et al
   The dual PI3K/mTOR-pathway inhibitor GDC-0084 achieves antitumor activity in PIK3CA-mutant breast cancer brain metastases.
   Clin Cancer Res. 2019 Feb 22. pii: 1078-0432.CCR-18-3049.
   PubMed     Text format     Abstract available
   
   
6. HALL PE, Lewis R, Syed N, Shaffer R, et al
   A Phase I study of pegylated arginine deiminase (pegargiminase), cisplatin and pemetrexed in argininosuccinate synthetase 1-deficient recurrent high-grade glioma.
   Clin Cancer Res. 2019 Feb 22. pii: 1078-0432.CCR-18-3729.
   PubMed     Text format     Abstract available
   
   
7. LASSMAN AB, Roberts-Rapp LA, Sokolova I, Song M, et al
   Comparison of Biomarker Assays for EGFR: Implications for Precision Medicine in Patients with Glioblastoma.
   Clin Cancer Res. 2019 Feb 22. pii: 1078-0432.CCR-18-3034.
   PubMed     Text format     Abstract available
   
   
8. TOMASZEWSKI W, Sanchez-Perez L, Gajewski TF, Sampson JH, et al
   Brain Tumor Micro-environment and Host State - Implications for Immunotherapy.
   Clin Cancer Res. 2019 Feb 25. pii: 1078-0432.CCR-18-1627.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Oncol

9. SHINDE A, Li R, Amini A, Glaser S, et al
   Can Immunotherapy Replace Radiotherapy in Melanoma Brain Metastases?
   J Clin Oncol. 2019 Feb 26:JCO1801982. doi: 10.1200/JCO.18.01982.
   PubMed     Text format    
   
   

   
   J Neurooncol

10. CAI M, Hou B, Luo L, Zhang B, et al
    Trans-eyebrow supraorbital keyhole approach to tuberculum sellae meningiomas: a series of 30 cases with long-term visual outcomes and recurrence rates.
    J Neurooncol. 2019 Feb 22. pii: 10.1007/s11060-019-03128.
    PubMed     Text format     Abstract available
    
    
11. MUSKENS IS, Hansen HM, Smirnov IV, Molinaro AM, et al
    Longer genotypically-estimated leukocyte telomere length is associated with increased meningioma risk.
    J Neurooncol. 2019 Feb 22. pii: 10.1007/s11060-019-03119.
    PubMed     Text format     Abstract available
    
    
12. WANG YC, Lee CC, Takami H, Shen S, et al
    Awake craniotomies for epileptic gliomas: intraoperative and postoperative seizure control and prognostic factors.
    J Neurooncol. 2019 Feb 25. pii: 10.1007/s11060-019-03131.
    PubMed     Text format     Abstract available
    
    
13. YAO J, Tan CHP, Schlossman J, Chakhoyan A, et al
    pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma.
    J Neurooncol. 2019 Feb 26. pii: 10.1007/s11060-019-03132.
    PubMed     Text format     Abstract available
    
    
14. CESCHIN R, Kocak M, Vajapeyam S, Pollack IF, et al
    Quantifying radiation therapy response using apparent diffusion coefficient (ADC) parametric mapping of pediatric diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium.
    J Neurooncol. 2019 Feb 27. pii: 10.1007/s11060-019-03133.
    PubMed     Text format     Abstract available
    
    

    
    J Neuropathol Exp Neurol

15. TEGLASI V, Csury DT, Dezso K, Bugyik E, et al
    Origin and Distribution of Connective Tissue and Pericytes Impacting Vascularization in Brain Metastases With Different Growth Patterns.
    J Neuropathol Exp Neurol. 2019 Feb 28. pii: 5366830. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
16. TORRE M, Meredith DM, Dubuc A, Solomon DA, et al
    Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
    J Neuropathol Exp Neurol. 2019 Feb 9. pii: 5366829. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Neuro Oncol

17. KOTECHA R, Kim JM, Miller JA, Juloori A, et al
    The Impact of Sequencing PD-1/PD-L1 Inhibitors and Stereotactic Radiosurgery for Patients with Brain Metastasis.
    Neuro Oncol. 2019 Feb 23. pii: 5364051. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
18. MIKLJA Z, Pasternak A, Stallard S, Nicolaides T, et al
    Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations.
    Neuro Oncol. 2019 Feb 26. pii: 5364813. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Neurosurgery

19. MCCARTHY D, Starke RM, Sheinberg D, Connolly ES, et al
    Treatment Synergy for Glioblastoma Multiforme with SynergySeq.
    Neurosurgery. 2019 Feb 27. pii: 5365775. doi: 10.1093.
    PubMed     Text format    
    
    
20. AL-HOLOU WN, Hodges TR, Everson RG, Freeman J, et al
    Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes.
    Neurosurgery. 2019 Feb 25. pii: 5364163. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

21. YOO KC, Suh Y, An Y, Lee HJ, et al
    Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation.
    Oncogene. 2018;37:3317-3328.
    PubMed     Text format     Abstract available
    
    
22. CONTRERAS-ZARATE MJ, Day NL, Ormond DR, Borges VF, et al
    Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
    Oncogene. 2019 Feb 22. pii: 10.1038/s41388-019-0756.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Genet

23. POULOS RC, Wong YT, Ryan R, Pang H, et al
    Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
    PLoS Genet. 2018;14:e1007779.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

24. VENTERO MP, Fuentes-Baile M, Quereda C, Perez-Valeciano E, et al
    Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.
    PLoS One. 2019;14:e0212581.
    PubMed     Text format     Abstract available
    
    
25. LUHTALA N, Hunter T
    Failure to detect functional transfer of active K-Ras protein from extracellular vesicles into recipient cells in culture.
    PLoS One. 2018;13:e0203290.
    PubMed     Text format     Abstract available
    
    
26. BERTERO L, Anfossi V, Osella-Abate S, Disanto MG, et al
    Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series.
    PLoS One. 2018;13:e0203570.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: